SynthesisBreast cancer research : BCR2015

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.

Jieping Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.